<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Autoimmune Dis</journal-id>
      <journal-title>Journal of Autoimmune Diseases</journal-title>
      <issn pub-type="epub">1740-2557</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2689867</article-id>
      <article-id pub-id-type="publisher-id">1740-2557-6-3</article-id>
      <article-id pub-id-type="pmid">19454015</article-id>
      <article-id pub-id-type="doi">10.1186/1740-2557-6-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Mialdea</surname>
            <given-names>Maria</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>mmialdea@yahoo.es</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Sangle</surname>
            <given-names>Shirish R</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>Shirish.Sangle@gstt.nhs.uk</email>
        </contrib>
        <contrib id="A3" corresp="yes" contrib-type="author">
          <name>
            <surname>D'Cruz</surname>
            <given-names>David P</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>david.d'cruz@kcl.ac.uk</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>The Lupus Research Unit, The Rayne Institute, 4thFloor, Lambeth Wing, St Thomas' Hospital, London, SE1 7EH, UK</aff>
      <pub-date pub-type="collection">
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>5</month>
        <year>2009</year>
      </pub-date>
      <volume>6</volume>
      <fpage>3</fpage>
      <lpage>3</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.jautoimdis.com/content/6/1/3"/>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>10</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>5</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2009 Mialdea et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2009</copyright-year>
        <copyright-holder>Mialdea et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Mialdea
               Maria
               
               mmialdea@yahoo.es
            </dc:author><dc:title>
            Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis
         </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Journal of Autoimmune Diseases 6(1): 3-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1740-2557(2009)6:1&#x0003c;3&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1740-2557</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <p>The antiphospholipid syndrome is an autoimmune disease characterised by recurrent arterial or venous thrombosis, pregnancy morbidity and the persistence of positive antiphospholipid antibodies. Many other clinical manifestations may occur including heart valve disease, livedo reticularis, thrombocytopenia and neurological manifestations such as migraine and seizures. We review a number of other manfestations including stenotic lesions, coronary artery disease and accelerated atherosclerosis, skeletal disorders and the concept of seronegative antiphospholipid syndrome.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>The antiphospholipid (Hughes) syndrome (APS), first described in 1983, is an autoimmune disease characterised by recurrent arterial or venous thrombosis, pregnancy morbidity and the persistence of positive antiphospholipid antibodies (aPL) [<xref ref-type="bibr" rid="B1">1</xref>]. Although only thrombosis and pregnancy loss are included in the revised classification criteria for APS [<xref ref-type="bibr" rid="B2">2</xref>], other features are also described [<xref ref-type="bibr" rid="B3">3</xref>]. These include heart valve disease, livedo reticularis, thrombocytopenia and neurological manifestations such as migraine and seizures. Recently a number of other features have been described in APS, which we discuss in this review.</p>
    </sec>
    <sec>
      <title>Stenotic lesions and vasculopathy</title>
      <p>Vascular occlusions are increasingly being recognized in patients with APS, although the exact etiology remains unclear [<xref ref-type="bibr" rid="B4">4</xref>]. We found a high prevalence of renal artery stenosis (RAS) in APS patients with uncontrolled hypertension compared to two control groups [<xref ref-type="bibr" rid="B5">5</xref>]. Other stenotic lesions such as coeliac [<xref ref-type="bibr" rid="B6">6</xref>] and intracerebral arterial stenosis [<xref ref-type="bibr" rid="B7">7</xref>] have also been reported. These stenotic lesions are smooth and well defined and are different from those seen in atherosclerotic RAS or fibromuscular dysplasia [<xref ref-type="bibr" rid="B5">5</xref>]. Interestingly histological examination in SLE patients with APS [<xref ref-type="bibr" rid="B8">8</xref>] and a case report of a resected superior mesenteric artery showed fibro-elastic thickening of the intima and thrombosis [<xref ref-type="bibr" rid="B9">9</xref>]. These findings suggest that thrombosis and intimal and smooth muscle hyperplasia may be responsible for the vasculopathy in APS. Preliminary reports suggest that anticoagulation with a high intensity international normalized ratio (INR) helps to control blood pressure and prevents re-stenosis in APS patients with RAS [<xref ref-type="bibr" rid="B10">10</xref>]. Similarly, other case reports emphasize the importance of high intensity INR in various stenotic lesions in APS patients [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>].</p>
    </sec>
    <sec>
      <title>Coronary artery disease</title>
      <p>Since the description of the APS syndrome, a number of cardiac manifestations have been described including cardiac valvular abnormalities (Libman-Sacks endocarditis) [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Coronary artery disease in young adults and coronary artery bypass graft occlusions have been reported in APS patients [<xref ref-type="bibr" rid="B15">15</xref>]. Although typical myocardial infarction (MI) is well described in patients with APS [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>], a number of reports have described MI and so called Syndrome X in the absence of atherosclerotic obstructive coronary artery lesions [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. Cardiac Syndrome X is defined by the presence of angina-like chest pain, a positive response to stress testing and normal coronary arteriograms. Syndrome X is seen in menopausal women [<xref ref-type="bibr" rid="B21">21</xref>] and so was linked to low oestrogen levels [<xref ref-type="bibr" rid="B22">22</xref>]. However, in APS patients, Syndrome X and MI were observed in young women who were not menopausal [<xref ref-type="bibr" rid="B23">23</xref>]. Histopathological findings in myocardial tissue of a patient with APS, showed a non-inflammatory micro-vasculopathy, characterized by thrombi, and further ultra-structural studies confirmed the thrombosis and demonstrated endothelial activation [<xref ref-type="bibr" rid="B24">24</xref>]. These findings support the hypothesis that the endothelial dysfunction and subsequent thrombosis seen in the APS patients may be responsible for Syndrome X/MI and argues against the lack of oestrogen theory. Experts in this field recommend long term anticoagulation in this group of patients [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>].</p>
    </sec>
    <sec>
      <title>Cerebral manifestations</title>
      <p>Although stroke is the only accepted neurological criterion for the diagnosis of APS, a number of other manifestations are observed in the APS. The spectrum of non- thrombotic cerebral manifestations may range from focal neurological lesions to diffuse global dysfunction. It includes severe headaches, often migranous, hemiplegic migraine, cognitive dysfunction and memory deficits, dysphasia (mixing or inappropriate words), behavioural changes and seizure disorders [<xref ref-type="bibr" rid="B25">25</xref>]. Extrapyramidal symptoms such as chorea have also been described in association with sub-cortical dementia in patients with APS [<xref ref-type="bibr" rid="B26">26</xref>]. Tektonidou et al noted a significant association between cognitive dysfunction and white matter lesions in the brain in patients with APS [<xref ref-type="bibr" rid="B27">27</xref>]. It is not uncommon to see white matter changes in the brain mimicking multiple sclerosis. Although a double blind cross-over trial comparing low molecular weight heparin with placebo failed to show positive results [<xref ref-type="bibr" rid="B28">28</xref>], clinical experience suggests that severe cognitive dysfunction and intractable headaches often respond to anticoagulation therapy in these patients [<xref ref-type="bibr" rid="B25">25</xref>].</p>
    </sec>
    <sec>
      <title>Skeletal manifestations of the APS</title>
      <p>APS may involve multiple organs such as kidney, brain, eye, ear and liver and it may also affect the skeleton. A prospective cohort study [<xref ref-type="bibr" rid="B29">29</xref>] together with several case reports of osteonecrosis in primary APS in the absence of osteoporosis [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>], have strengthened the possible association between aPL and osteonecrosis. Our own experience is that non-traumatic metatarsal fractures are more prevalent in APS/aPL positive patients [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. Interestingly most had normal DEXA scans, none had any preceding trauma and none had received high doses of steroids. To assess the true prevalence of these fractures and their relation to aPL, a prospective study is needed in both symptomatic and asymptomatic patients.</p>
    </sec>
    <sec>
      <title>Endothelial dysfunction</title>
      <p>Accelerated atheroma has been described as a feature of APS as in other autoimmune inflammatory conditions. APS/aPL are associated with accelerated atherosclerosis [<xref ref-type="bibr" rid="B34">34</xref>] by targeting some of the steps that constitute early atherogenesis from endothelial activation to oxidized LDL uptake by foam macrophages [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. The ankle-brachial index (ABI) was found to be abnormal in patients with APS with thrombosis as well as in APS patients with pregnancy morbidity without thrombosis [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. A recent study by Charakida et al of endothelial assessment in patients with APS is worth mentioning. She studied 90 age, sex and cardiovascular risk factor profile matched patients with primary APS and a control group of 90 people with negative aPL. High resolution ultrasound was used to determine carotid intima media thickness (cIMT), endothelium dependent flow mediated dilatation (FMD) and endothelium independent nitroglycerine mediated dilatation of the brachial artery. This data showed significantly reduced FMD and increased cIMT in APS patients as compared to healthy individuals [<xref ref-type="bibr" rid="B39">39</xref>]. This corroborates previous observations by Medina et al [<xref ref-type="bibr" rid="B40">40</xref>]. Similarly, observations by Ames et al of subclinical atherosclerosis using intima-medial thickness in patients with primary APS in their 4<sup>th </sup>decade are worth mentioning [<xref ref-type="bibr" rid="B41">41</xref>]. This data indicates that endothelial dysfunction and pre-clinical atherosclerosis is prevalent in APS/aPL patients. The increased prevalence of an abnormal ABI in patients with APS, suggests that a large vessel vasculopathy could be a contributing factor to both thrombosis and pregnancy loss in APS [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>].</p>
    </sec>
    <sec>
      <title>Complications following renal biopsy in patients with APS/aPL</title>
      <p>Although APS is by definition a hypercoaguable state, a surprising recent preliminary report by Chaib et al found an increased risk of bleeding complications following renal biopsy in patients with lupus nephritis (LN) and APS/aPL as compared to LN alone [<xref ref-type="bibr" rid="B42">42</xref>]. This single centre study examined &gt; 200 patients of which 86 were APS/aPL positive. The study identified a positive lupus anticoagulant and elevated serum creatinine levels as significant risk factors for post biopsy bleeding complications.</p>
    </sec>
    <sec>
      <title>Livedo reticularis and "Seronegative APS"</title>
      <p>"Sero-negative" APS has remained an enigma and the concept is controversial. According to classification criteria for APS, aPL (lupus anticoagulant and anticardiolipin antibodies) and Beta 2 Glycoprotein I (B2GPI) antibodies are essential for the classification of patients with APS. Although aPL and anti-B2GPI are sensitive tests, they are not sensitive enough to pick up all patients with APS. A small group of APS patients remain persistently negative for routine assays of aPL [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>]. Livedo reticularis was included in the original clinical description of the APS. Frances et al reported significant associations between pathological livedo reticularis (racemosa) and cerebral or ocular ischemic arterial events, seizures, heart valve abnormalities, hypertension and Raynaud's phenomenon in patients with APS [<xref ref-type="bibr" rid="B45">45</xref>]. As with APS, livedo reticularis in the absence of aPL has been associated with pregnancy morbidity and abnormal ABI [<xref ref-type="bibr" rid="B46">46</xref>]. Livedo reticularis shares a number of features with APS such as pregnancy loss, arterial thrombosis, heart valve abnormalities and seizures [<xref ref-type="bibr" rid="B47">47</xref>] and indeed it is the most common cutaneous manifestation of APS [<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B49">49</xref>]. There is therefore increasing evidence that "seronegative" APS does exist and it may be that serological markers other than aPL and anti-B2GPI are important in these patients. Pathological livedo reticularis may therefore be a clinical marker of the "seronegative APS" [<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B50">50</xref>].</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>The spectrum of APS is not limited to thrombosis or pregnancy morbidity and clinicians should be aware of the broad range of manifestations with multi-system involvement.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>MM has written the manuscript, SRS has conceived and compiled the material and helped to write the manuscript and DPD has supervised the drafting of the manuscript. All authors have read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hughes</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Thrombosis, abortion, cerebral disease and the lupus anticoagulant</article-title>
          <source>BMJ</source>
          <year>1983</year>
          <volume>287</volume>
          <fpage>1088</fpage>
          <lpage>1089</lpage>
          <pub-id pub-id-type="pmid">6414579</pub-id>
          <pub-id pub-id-type="doi">10.1136/bmj.287.6399.1088</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyakis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lockshin</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Atsumi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Branch</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Brey</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Cervera</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Derksen</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>DE Groot</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Meroni</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Reber</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Shoenfeld</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tincani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vlachoyiannopoulos</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Krilis</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)</article-title>
          <source>J Thromb Haemost</source>
          <year>2006</year>
          <volume>4</volume>
          <fpage>295</fpage>
          <lpage>306</lpage>
          <pub-id pub-id-type="pmid">16420554</pub-id>
          <pub-id pub-id-type="doi">10.1111/j.1538-7836.2006.01753.x</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Cervera</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Asherson</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Font</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gil</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Coltart</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>V&#xE1;zquez</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Par&#xE9;</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ingelmo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oliver</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus</article-title>
          <source>Lancet</source>
          <year>1990</year>
          <volume>335</volume>
          <fpage>1541</fpage>
          <lpage>1544</lpage>
          <pub-id pub-id-type="pmid">1972484</pub-id>
          <pub-id pub-id-type="doi">10.1016/0140-6736(90)91373-I</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christodoulou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sangle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome</article-title>
          <source>Rheumatology (Oxford)</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>907</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">17403711</pub-id>
          <pub-id pub-id-type="doi">10.1093/rheumatology/kem040</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sangle</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Jan</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Karim</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Abbs</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension</article-title>
          <source>Ann Rheum Dis</source>
          <year>2003</year>
          <volume>62</volume>
          <fpage>999</fpage>
          <lpage>1002</lpage>
          <pub-id pub-id-type="pmid">12972481</pub-id>
          <pub-id pub-id-type="doi">10.1136/ard.62.10.999</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sangle</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Jan</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GRV</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid antibodies</article-title>
          <source>Clin Exp Rheumatol</source>
          <year>2006</year>
          <volume>24</volume>
          <fpage>349</fpage>
          <pub-id pub-id-type="pmid">16870110</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sangle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jan</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>Intracerebral arterial stenosis with neurological events associated with antiphospholipid syndrome</article-title>
          <source>Rheumatology (Oxford)</source>
          <year>2005</year>
          <volume>44</volume>
          <fpage>948</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">15840600</pub-id>
          <pub-id pub-id-type="doi">10.1093/rheumatology/keh645</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sipek-Dolnicar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hojnik</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bozic</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Vizjak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rozman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ferluga</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Clinical presentations and vascular histopathology in autopsied patients with systemic lupus erythematosus and anticardiolipin antibodies</article-title>
          <source>Clin Exp Rheumatol</source>
          <year>2002</year>
          <volume>20</volume>
          <fpage>335</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">12102469</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kojima</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Naito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Iwai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hirose</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Isobe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takano</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Antiphospholipid syndrome complicated by thrombosis of the superior mesenteric artery, co-existence of smooth muscle hyperplasia</article-title>
          <source>Intern Med</source>
          <year>1997</year>
          <volume>36</volume>
          <fpage>528</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">9240507</pub-id>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.36.528</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sangle</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Abbs</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation</article-title>
          <source>Rheumatology (Oxford)</source>
          <year>2005</year>
          <volume>44</volume>
          <fpage>372</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="pmid">15572388</pub-id>
          <pub-id pub-id-type="doi">10.1093/rheumatology/keh490</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenthal</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sangle</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>Treatment of mesenteric angina with antiphospholipid (Hughes) syndrome and coeliac artery stenosis</article-title>
          <source>Ann Rheum Dis</source>
          <year>2006</year>
          <volume>65</volume>
          <fpage>1398</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16973790</pub-id>
          <pub-id pub-id-type="doi">10.1136/ard.2005.050344</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Remondino</surname>
              <given-names>GI</given-names>
            </name>
            <name>
              <surname>Mysler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pissano</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Furattini</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Basta</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Presas</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Allievi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A reversible bilateral renal artery stenosis in association with antiphospholipid syndrome</article-title>
          <source>Lupus</source>
          <year>2000</year>
          <volume>9</volume>
          <fpage>65</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">10713649</pub-id>
          <pub-id pub-id-type="doi">10.1177/096120330000900112</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cervera</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Coronary and valvular syndromes and antiphospholipid antibodies</article-title>
          <source>Thromb Res</source>
          <year>2004</year>
          <volume>114</volume>
          <fpage>501</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="pmid">15507284</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.thromres.2004.06.026</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tenedios</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Erkan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lockshin</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Cardiac involvement in the antiphospholipid syndrome</article-title>
          <source>Lupus</source>
          <year>2005</year>
          <volume>14</volume>
          <fpage>691</fpage>
          <lpage>696</lpage>
          <pub-id pub-id-type="pmid">16218469</pub-id>
          <pub-id pub-id-type="doi">10.1191/0961203305lu2202oa</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaplan</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Chartash</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Pizzarello</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Furie</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Cardiac manifestations of antiphospholipid syndrome</article-title>
          <source>Am Heart J</source>
          <year>1992</year>
          <volume>124</volume>
          <fpage>1331</fpage>
          <lpage>1338</lpage>
          <pub-id pub-id-type="pmid">1442504</pub-id>
          <pub-id pub-id-type="doi">10.1016/0002-8703(92)90420-Z</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vaarala</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Antiphospholipid antibodies and myocardial infarction</article-title>
          <source>Lupus</source>
          <year>1998</year>
          <volume>7</volume>
          <fpage>S132</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="pmid">9814690</pub-id>
          <pub-id pub-id-type="doi">10.1177/096120339800700229</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hamsten</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Norberg</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bjorkholm</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>de Faire</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Holm</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Antibodies to cardiolipin in young survivors of myocardial infarctions: an association with recurrent cardiovascular events</article-title>
          <source>Lancet</source>
          <year>1986</year>
          <volume>18</volume>
          <fpage>113</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="pmid">2867345</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(86)92258-0</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nair</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GRV</given-names>
            </name>
          </person-group>
          <article-title>Syndrome X and Hughes syndrome</article-title>
          <source>Lupus</source>
          <year>2002</year>
          <volume>11</volume>
          <fpage>332</fpage>
          <pub-id pub-id-type="pmid">12090572</pub-id>
          <pub-id pub-id-type="doi">10.1191/0961203302lu210xx</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lagana</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Baratta</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tubani</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Golluscio</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Delfino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rossi Fanelli</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Myocardial infarction with normal coronary arteries in a patient with primary antiphospholipid syndrome. Case report and literature review</article-title>
          <source>Angiology</source>
          <year>2001</year>
          <volume>52</volume>
          <fpage>785</fpage>
          <lpage>788</lpage>
          <pub-id pub-id-type="pmid">11716332</pub-id>
          <pub-id pub-id-type="doi">10.1177/000331970105201109</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise</article-title>
          <source>Int J Clin Pract</source>
          <year>2007</year>
          <volume>61</volume>
          <fpage>379</fpage>
          <lpage>384</lpage>
          <pub-id pub-id-type="pmid">17313603</pub-id>
          <pub-id pub-id-type="doi">10.1111/j.1742-1241.2006.01245.x</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Pepine</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Kelsey</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Sopko</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Mankad</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sharaf</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Bittner</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bairey Merz</surname>
              <given-names>CN</given-names>
            </name>
          </person-group>
          <article-title>Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI sponsored Women's ischaemia Syndrome Evaluation (WISE) study</article-title>
          <source>Eur Heart J</source>
          <year>2006</year>
          <volume>27</volume>
          <fpage>1408</fpage>
          <lpage>1415</lpage>
          <pub-id pub-id-type="pmid">16720691</pub-id>
          <pub-id pub-id-type="doi">10.1093/eurheartj/ehl040</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaski</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Cardiac syndrome X in women: the role of oestrogen deficiency</article-title>
          <source>Heart</source>
          <year>2006</year>
          <volume>92</volume>
          <fpage>35</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">16614266</pub-id>
          <pub-id pub-id-type="doi">10.1136/hrt.2005.070318</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sangle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Syndrome X (angina pectoris with normal coronary arteries) and myocardial infarction in patients with anti-phospholipid (Hughes) syndrome</article-title>
          <source>Lupus</source>
          <year>2008</year>
          <volume>17</volume>
          <fpage>83</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="pmid">18250128</pub-id>
          <pub-id pub-id-type="doi">10.1177/0961203307086036</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kattwinkel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Villanueva</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Labib</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Aretz</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Walek</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Klenz</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Myocardial infarction caused by microvasculopathy in a patient with primary antiphospholipid syndrome</article-title>
          <source>Ann Int Med</source>
          <year>1992</year>
          <volume>116</volume>
          <fpage>974</fpage>
          <lpage>976</lpage>
          <pub-id pub-id-type="pmid">1586106</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanna</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cuadrado</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Cerebral manifestations in the antiphospholipid (Hughes) syndrome</article-title>
          <source>Rheum Dis Clin North Am</source>
          <year>2006</year>
          <volume>32</volume>
          <fpage>465</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">16880079</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.rdc.2006.05.010</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciubotaru</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Esfahani</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Benedict</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Wild</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Baer</surname>
              <given-names>AN</given-names>
            </name>
          </person-group>
          <article-title>Chorea and rapidly progressive subcortical dementia in antiphospholipid syndrome</article-title>
          <source> J Clin Rheumatol</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>332</fpage>
          <lpage>339</lpage>
          <pub-id pub-id-type="pmid">17041404</pub-id>
          <pub-id pub-id-type="doi">10.1097/00124743-200212000-00010</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tektonidou</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Varsou</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kotoulas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Antoniou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Moutsopolous</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings</article-title>
          <source>Arch Intern Med </source>
          <year>2006</year>
          <volume>166</volume>
          <fpage>2278</fpage>
          <lpage>2284</lpage>
          <pub-id pub-id-type="pmid">17101948</pub-id>
          <pub-id pub-id-type="doi">10.1001/archinte.166.20.2278</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cuadrado</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GRV</given-names>
            </name>
          </person-group>
          <article-title>Migraine in Hughes syndrome &#x2013; heparin as a therapeutic trial?</article-title>
          <source>QJM </source>
          <year>2001</year>
          <volume>94</volume>
          <fpage>114</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="pmid">11181989</pub-id>
          <pub-id pub-id-type="doi">10.1093/qjmed/94.2.114</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tektonoidou</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Malagari</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vlachoyiannopoulos</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Kelekis</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Moutsopoulos</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging</article-title>
          <source>Arthritis Rheum</source>
          <year>2003</year>
          <volume>48</volume>
          <fpage>732</fpage>
          <lpage>736</lpage>
          <pub-id pub-id-type="pmid">12632427</pub-id>
          <pub-id pub-id-type="doi">10.1002/art.10835</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seleznick</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Silveira</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Espinoza</surname>
              <given-names>LR</given-names>
            </name>
          </person-group>
          <article-title>Avascular necrosis associated with anticardiolipin antibodies</article-title>
          <source>J Rheumatol</source>
          <year>1991</year>
          <volume>18</volume>
          <fpage>1416</fpage>
          <lpage>1417</lpage>
          <pub-id pub-id-type="pmid">1757948</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egan</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Munn</surname>
              <given-names>RK</given-names>
            </name>
          </person-group>
          <article-title>Catastrophic antiphospholipid syndrome presenting with multiple thromboses and sites of avascular necrosis</article-title>
          <source>J Rheumatol</source>
          <year>1994</year>
          <volume>21</volume>
          <fpage>2376</fpage>
          <lpage>2379</lpage>
          <pub-id pub-id-type="pmid">7699646</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sangle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures</article-title>
          <source>Ann Rheum Dis</source>
          <year>2004</year>
          <volume>63</volume>
          <fpage>1241</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">15361379</pub-id>
          <pub-id pub-id-type="doi">10.1136/ard.2003.016105</pub-id>
        </citation>
      </ref>
      <ref id="B33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vasoo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sangle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zain</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome</article-title>
          <source>Lupus</source>
          <year>2005</year>
          <volume>14</volume>
          <fpage>339</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">15934432</pub-id>
          <pub-id pub-id-type="doi">10.1191/0961203305lu2146rr</pub-id>
        </citation>
      </ref>
      <ref id="B34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Sangle</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>Antiphospholipid (Hughes) syndrome and atheroma</article-title>
          <source>Lupus</source>
          <year>2006</year>
          <volume>15</volume>
          <fpage>55</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="doi">10.1177/0961203306071669</pub-id>
        </citation>
      </ref>
      <ref id="B35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis</article-title>
          <source>A Rev Biochem</source>
          <year>1983</year>
          <volume>52</volume>
          <fpage>223</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.bi.52.070183.001255</pub-id>
        </citation>
      </ref>
      <ref id="B36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henriksen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mahoney</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Steinburg</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Enhanced macrophage degradation of biologically modified low density lipoprotein</article-title>
          <source>Arteriosclerosis</source>
          <year>1983</year>
          <volume>3</volume>
          <fpage>149</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">6838433</pub-id>
        </citation>
      </ref>
      <ref id="B37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bar&#xF3;n</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data</article-title>
          <source>Ann Rheum Dis</source>
          <year>2005</year>
          <volume>64</volume>
          <fpage>144</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">15608314</pub-id>
          <pub-id pub-id-type="doi">10.1136/ard.2003.016204</pub-id>
        </citation>
      </ref>
      <ref id="B38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christodoulou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zain</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bertolaccini</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Sangle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of an abnormal ankle-brachial index in patients with antiphospholipid syndrome with pregnancy loss but without thrombosis: a controlled study</article-title>
          <source>Ann Rheum Dis</source>
          <year>2006</year>
          <volume>65</volume>
          <fpage>683</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">16611867</pub-id>
          <pub-id pub-id-type="doi">10.1136/ard.2005.037911</pub-id>
        </citation>
      </ref>
      <ref id="B39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Charakida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Halcox</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Sangle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Donald</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Mackworth-Young</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Deanfield</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Endothelial Dysfunction and Increased Carotid Intima-Media Thickness in Primary Antiphospholipid Syndrome</article-title>
          <source>Arthritis Rheum</source>
          <year>2006</year>
          <volume>54</volume>
          <fpage>557</fpage>
          <lpage>558</lpage>
          <pub-id pub-id-type="pmid">16447232</pub-id>
          <pub-id pub-id-type="doi">10.1002/art.21569</pub-id>
        </citation>
      </ref>
      <ref id="B40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Medina</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Casaos</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jara</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Vera-Lastra</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Fuentes</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barile</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Salas</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome</article-title>
          <source>Ann Rheum Dis</source>
          <year>2003</year>
          <volume>62</volume>
          <fpage>607</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">12810420</pub-id>
          <pub-id pub-id-type="doi">10.1136/ard.62.7.607</pub-id>
        </citation>
      </ref>
      <ref id="B41">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Margarita</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Batuca</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Scenna</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Alves</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Iannaccone</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Matsuura</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ames</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Subclinical atherosclerosis in primary antiphospholipid syndrome</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2007</year>
          <volume>1108</volume>
          <fpage>475</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">17894012</pub-id>
          <pub-id pub-id-type="doi">10.1196/annals.1422.050</pub-id>
        </citation>
      </ref>
      <ref id="B42">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaib</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Mellilo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sangle</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Sabharwal</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tungekar</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Abbs</surname>
              <given-names>IC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antiphospholipid antibodies and increased bleeding complications following renal biopsy: a single centre study</article-title>
          <source>Arthritis Rheum</source>
          <year>2007</year>
          <volume>56</volume>
          <fpage>S740</fpage>
        </citation>
      </ref>
      <ref id="B43">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Roubey</surname>
              <given-names>RAS</given-names>
            </name>
            <name>
              <surname>Roch</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Amengual</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Atsumi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GRV</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Khamashta MA</surname>
            </name>
          </person-group>
          <article-title>Antiphospholipid antibody-negative syndrome &#x2013; other phospholipids</article-title>
          <source>Hughes Syndrome Antiphospholipid syndrome</source>
          <year>2000</year>
          <publisher-name>London: Springer</publisher-name>
          <fpage>253</fpage>
          <lpage>60</lpage>
        </citation>
      </ref>
      <ref id="B44">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carmo-Pereira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bertolaccini</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Escudero-Conteras</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity</article-title>
          <source>Ann Rheum Dis</source>
          <year>2003</year>
          <volume>62</volume>
          <fpage>540</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">12759291</pub-id>
          <pub-id pub-id-type="doi">10.1136/ard.62.6.540</pub-id>
        </citation>
      </ref>
      <ref id="B45">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frances</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Niang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Laffitte</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pelletier</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Costedoat</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Piette</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases</article-title>
          <source>Arthritis Rheum</source>
          <year>2005</year>
          <volume>52</volume>
          <fpage>1785</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">15934071</pub-id>
          <pub-id pub-id-type="doi">10.1002/art.21041</pub-id>
        </citation>
      </ref>
      <ref id="B46">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sangle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Christodoulou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Paul</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>D'Cruz</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>The point prevalence of an abnormal ankle-brachial index in antiphospholipid antibody negative patients with livedo reticularis: a controlled study</article-title>
          <source>Ann Rheum Dis</source>
          <year>2008</year>
          <volume>67</volume>
          <fpage>276</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">18192306</pub-id>
          <pub-id pub-id-type="doi">10.1136/ard.2007.074567</pub-id>
        </citation>
      </ref>
      <ref id="B47">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frances</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Papo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wechsler</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Laporte</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Biousse</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Piette</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Sneddon Syndrome with or without antiphospholipid antibodies, A comparative study in 46 patients</article-title>
          <source>Medicine (Baltimore)</source>
          <year>1999</year>
          <volume>78</volume>
          <fpage>209</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="pmid">10424203</pub-id>
          <pub-id pub-id-type="doi">10.1097/00005792-199907000-00001</pub-id>
        </citation>
      </ref>
      <ref id="B48">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weinstein</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Piette</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous manifestations of antiphospholipid antibody syndrome</article-title>
          <source>Hematol Oncol Clin North Am</source>
          <year>2008</year>
          <volume>22</volume>
          <fpage>67</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">18207066</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.hoc.2007.10.011</pub-id>
        </citation>
      </ref>
      <ref id="B49">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kriseman</surname>
              <given-names>YL</given-names>
            </name>
            <name>
              <surname>Nash</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2007</year>
          <fpage>112</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">17467850</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.jaad.2006.11.033</pub-id>
        </citation>
      </ref>
      <ref id="B50">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hughes</surname>
              <given-names>GRV</given-names>
            </name>
            <name>
              <surname>Khamashta</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Seronegative antiphospholipid syndrome</article-title>
          <source>Ann Rheum Dis</source>
          <year>2003</year>
          <volume>62</volume>
          <fpage>1127</fpage>
          <pub-id pub-id-type="pmid">14644846</pub-id>
          <pub-id pub-id-type="doi">10.1136/ard.2003.006163</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
